Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-22

FDA Approved: BIMATOPROST — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the original application for bimatoprost from Amneal Pharmaceuticals NY LLC, enabling a generic version of the ophthalmic therapy for open-angle gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

ORIG AP for BIMATOPROST (BIMATOPROST)